
FDA Approves Rx/Dx Combination for Acute Myeloid Leukemia
NEW YORK (GenomeWeb) – The US Food and Drug Administration today approved Novartis’ acute myeloid leukemia drug Rydapt (midostaurin) in combination with chemotherapy alongside Invivoscribe […]